BioBridge-Led Team Chosen to Develop Clinical-Grade Stem Cell Manufacturing Process
The Medical Technology Enterprise Consortium has awarded a BioBridge Global-led group of organizations a three-year, $7.8 million contract to develop a clinical-grade process for stem cell manufacturing techniques. BBG said Monday the team will work to create large-scale stem cell manufacturing economical platforms in an effort to give researchers human bone marrow-derived mesenchymal stem cells for study, therapeutic […] More